OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 69 filers reported holding OCULAR THERAPEUTIX INC in Q4 2017. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $907,000 | -33.3% | 146,752 | 0.0% | 0.07% | -36.4% |
| Q2 2017 | $1,360,000 | -0.1% | 146,752 | 0.0% | 0.11% | -2.7% |
| Q1 2017 | $1,362,000 | -34.0% | 146,752 | -40.5% | 0.11% | -40.8% |
| Q4 2016 | $2,065,000 | -4.5% | 246,752 | -21.6% | 0.19% | -4.0% |
| Q3 2016 | $2,162,000 | +98.7% | 314,752 | +43.2% | 0.20% | +53.1% |
| Q2 2016 | $1,088,000 | -48.8% | 219,752 | 0.0% | 0.13% | -56.2% |
| Q1 2016 | $2,123,000 | +64.1% | 219,752 | +138.9% | 0.30% | +47.0% |
| Q3 2015 | $1,294,000 | +11.8% | 92,000 | +67.3% | 0.20% | +12.8% |
| Q2 2015 | $1,157,000 | -49.9% | 55,000 | 0.0% | 0.18% | -44.1% |
| Q1 2015 | $2,309,000 | – | 55,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |